Skip to main content
All lobbying filings

BOCKORNY GROUP, INC.

BOCKORNY GROUP, INC. filed a Q2 termination report for ELANCO ANIMAL HEALTH on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for ELANCO ANIMAL HEALTH · Producer of medicines and vaccines for pets and livestock.

All filings by BOCKORNY GROUP, INC. · Everything ELANCO ANIMAL HEALTH has reported

 Filing · LD-2 quarterly report Q2 termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Indiana
Representation ended
May 31, 2026
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Animals

S. 1842 and HR 6687 - Innovative FEED Act. Issues related to the approval of patented dog and cat collars.

Agriculture

Approval process for feed ingredient Farm Bill conservation issues - no specific legislation

Taxation/Internal Revenue Code

Issues related to tax reconciliation bill.

Trade (domestic/foreign)

Issues related to U.S. tariff policies.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem